Last reviewed · How we verify
NCT05213988
Effects on Glucose Homeostasis of Changes in Plasma Lipoproteins Induced by Nutritional and Pharmacologic Strategies
NA trial testing Intermittent Fasting in Glucose Metabolism Disorders in 50 participants. Status unknown.
1 January 2025
Quick facts
| Lead sponsor | Azienda Ospedaliero, Universitaria Pisana |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | basic science |
| Enrollment | 50 |
| Start date | 30 July 2018 |
| Primary completion | 1 January 2025 |
| Estimated completion | 1 January 2025 |
| Sites | 1 location across Italy |
Drugs / interventions tested
- Intermittent Fasting
- Fibrates — full drug profile →
- Low-Carbohydrate/High-Protein diet
Conditions studied
- Glucose Metabolism Disorders — all drugs for Glucose Metabolism Disorders →
Sponsor
Azienda Ospedaliero, Universitaria Pisana — full company profile →
Who can join
Adults 18 to 65, any sex, with Glucose Metabolism Disorders. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The investigators aim to examine the impact of changes in plasma lipoproteins induced by nutritional and pharmacological interventions on glucose homeostasis
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05213988
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Intermittent Fasting
Trials testing the same drug.
- NCT06615817 — Intermittent Fasting, Mediterranean Diet and NAFLD · NA · not yet recruiting
- NCT06106477 — Impact of Intermittent Fasting on Biomarkers of Inflammation and Health-Related Quality of Life: A Feasibility Trial for · NA · recruiting
- NCT06386887 — Fasting During Neoadjuvant Chemotherapy in Patient With Epithelial Ovarian Cancer · NA · recruiting
- NCT06766747 — Efficacy of Intermittent Fasting Versus Continuous Caloric Restriction in the Treatment of Significant Weight Regain Aft · NA · completed
- NCT06172283 — Intermittent Fasting in Prostate Cancer Patients Receiving Androgen Deprivation Therapy · NA · recruiting
Other recruiting trials for Glucose Metabolism Disorders
Currently open trials in the same condition.
- NCT06763562 — Food Orders on Blood Glucose and Fuel Use At Rest · NA · recruiting
- NCT06674980 — Clinical Trial Assessing Human Placental Membrane Products and Standard of Care Versus Standard of Care in Nonhealing DF · NA · recruiting
- NCT06051318 — Relationship Between Individual Effect of Diet on Postprandial Glycemia and Gut Microbiome Profile in Healthy Subjects · NA · recruiting
- NCT06358716 — Glycaemic Index Determination in Oral Nutrition Supplements · NA · recruiting
- NCT06878781 — Postprandial Metabolome and Metabolic Flexibility · NA · recruiting
Other Azienda Ospedaliero, Universitaria Pisana trials
Trials by the same sponsor.
- NCT07512453 — Study in Patients With Osteoporosis and Fragility Fractures to Estimate the Extent and Impact of Delayed Administration · not yet recruiting
- NCT06333132 — Deciphering the Role of Incretin Hormones in Weight Loss-induced Remission of Type 2 Diabetes (DIABeat) · NA · unknown
- NCT07250607 — Extreme Phenotypes to Identify Susceptibility of Patients Living With Type 2 to Diabetes Related Complications · active not recruiting
- NCT07132086 — Prospective Observational Study on the Effectiveness of Daridorexant in Chronic Insomnia in a Real-World Setting · completed
- NCT06876948 — NENCA Study on Neurological Complications of Long COVID-19 in Children and Adolescents; Neurophysiological, Electroencep · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05213988 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Azienda Ospedaliero, Universitaria Pisana
- Last refreshed: 28 January 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05213988.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing